Price T Rowe Associates Inc Medpace Holdings, Inc. Transaction History

Price T Rowe Associates Inc

  • $869 Billion
  • Q3 2024

A detailed history of Price T Rowe Associates Inc transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 131,532 shares of MEDP stock, worth $45.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
131,532
Previous 154,287 14.75%
Holding current value
$45.1 Million
Previous $63.5 Million 30.9%
% of portfolio
0.01%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$320.58 - $457.29 $7.29 Million - $10.4 Million
-22,755 Reduced 14.75%
131,532 $43.9 Million
Q2 2024

Aug 14, 2024
SELL
$372.0 - $424.34 $37.9 Million - $43.2 Million
-101,813 Reduced 39.76%
154,287 $63.5 Million
Q1 2024

May 15, 2024
BUY
$284.87 - $413.31 $917,851 - $1.33 Million
3,222 Added 1.27%
256,100 $104 Million
Q4 2023

Feb 14, 2024
SELL
$227.52 - $312.68 $3.1 Million - $4.26 Million
-13,619 Reduced 5.11%
252,878 $77.5 Million
Q3 2023

Nov 14, 2023
SELL
$233.98 - $281.67 $13.7 Million - $16.5 Million
-58,619 Reduced 18.03%
266,497 $64.5 Million
Q2 2023

Aug 14, 2023
SELL
$187.26 - $240.17 $354,857 - $455,122
-1,895 Reduced 0.58%
325,116 $78.1 Million
Q1 2023

May 15, 2023
SELL
$174.31 - $239.52 $2.56 Million - $3.52 Million
-14,710 Reduced 4.3%
327,011 $61.5 Million
Q4 2022

Feb 14, 2023
SELL
$153.06 - $226.57 $2.62 Million - $3.88 Million
-17,146 Reduced 4.78%
341,721 $72.6 Million
Q3 2022

Nov 14, 2022
SELL
$145.13 - $182.49 $4.46 Million - $5.61 Million
-30,722 Reduced 7.89%
358,867 $56.4 Million
Q2 2022

Aug 15, 2022
SELL
$130.2 - $168.03 $11.5 Million - $14.8 Million
-88,337 Reduced 18.48%
389,589 $58.3 Million
Q1 2022

May 16, 2022
SELL
$138.87 - $214.31 $2.13 Million - $3.29 Million
-15,330 Reduced 3.11%
477,926 $78.2 Million
Q4 2021

Feb 14, 2022
SELL
$182.74 - $227.9 $3.65 Million - $4.55 Million
-19,973 Reduced 3.89%
493,256 $107 Million
Q3 2021

Nov 15, 2021
SELL
$170.18 - $198.21 $32.3 Million - $37.6 Million
-189,782 Reduced 27.0%
513,229 $97.1 Million
Q2 2021

Aug 16, 2021
SELL
$158.62 - $194.3 $8.54 Million - $10.5 Million
-53,841 Reduced 7.11%
703,011 $124 Million
Q1 2021

May 17, 2021
SELL
$132.02 - $168.26 $3.17 Million - $4.04 Million
-24,021 Reduced 3.08%
756,852 $124 Million
Q4 2020

Feb 16, 2021
BUY
$109.38 - $149.19 $85.4 Million - $116 Million
780,873 New
780,873 $109 Million

Others Institutions Holding MEDP

# of Institutions
616
Shares Held
25.1M
Call Options Held
42.8K
Put Options Held
207K
View Full List

About Medpace Holdings, Inc.

MEDP Quotes by TradingView
  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $10.7B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email